Dynamic oxygen-enhanced magnetic resonance imaging of the lung in asthma—Initial experience  by Zhang, Wei-Juan et al.
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Objectives:  To prospectively  estimate  the  feasibility  and  reproducibility  of  dynamic  oxygen-enhanced
magnetic  resonance  imaging  (OE-MRI)  in  the  assessment  of  regional  oxygen  delivery,  uptake  and  washout
in  asthmatic  lungs.
Materials and  methods:  The  study  was  approved  by  the  National  Research  Ethics  Committee  and  written
informed  consent  was obtained.  Dynamic  OE-MRI  was  performed  twice  at one  month  apart  on  four  mild
asthmatic  patients  (23  ± 5 years  old,  FEV1 =  96  ± 3% of  predicted  value)  and  six severe  asthmatic  patients
(41  ± 12 years  old,  FEV1 = 60 ± 14%  of predicted  value)  on a 1.5  T MR  scanner  using  a two-dimensional  T1-
weighted  inversion-recovery  turbo  spin  echo  sequence.  The  enhancing  fraction  (EF),  the  maximal  change
in the  partial  pressure  of  oxygen  in  lung  tissue  (PO2max  l) and  arterial  blood  of  the  aorta  (PO2max a), and
the  oxygen  wash-in  (up l , up  a) and wash-out  (down  l , down  a) time  constants  were  extracted  and  com-
pared  between  groups  using  the independent-samples  t-test  (two-tailed).  Correlations  between  imaging
readouts  and  clinical  measurements  were  assessed  by  Pearson’s  correlation  analysis.  Bland–Altman  anal-
ysis was  used  to estimate  the  levels  of  agreement  between  the repeat  scans  and  the  intra-observer
agreement  in  the  MR  imaging  readouts.
Results:  The  severe  asthmatic  group  had  signiﬁcantly  smaller  EF  (70  ±  16%)  and  median  PO2max  l
(156  ±  52  mmHg)  and  signiﬁcantly  larger  interquartile  range  of  up  l (0.84  ±  0.26  min)  than  the  mild  asth-
matic  group  (95  ± 3%,  P = 0.014;  281 ± 40 mmHg,  P  =  0.004;  0.20  ± 0.07  min,  P = 0.001,  respectively).  EF,
median  PO2max  l and  down  l and  the interquartile  range  of  up  l and  down  l were  signiﬁcantly  correlated
with  age  and pulmonary  function  test  parameters  (r = −0.734 to  −0.927,  0.676–0.905;  P = 0.001–0.045).
Median PO2max  l was  signiﬁcantly  correlated  with  PO2max  a (r =  0.745,  P = 0.013).  Imaging  readouts
showed good  one-month  reproducibility  and  good  intra-observer  agreement  (mean  bias  between
repeated  scans  and  between  two  observations  did  not  signiﬁcantly  deviate  from  zero).
Conclusions:  Dynamic  OE-MRI  is feasible  in  asthma  and  sensitive  to  the  severity  of  disease.  The  technique
provides  indices  related  to regional  oxygen  delivery,  uptake  and  washout  that  show  good  one month
reproducibility  and  intra-observer  agreement.
©  2014  The  Authors.  Publis
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1. Introduction
Functional lung imaging modalities utilized in asthma studies
to date include scintigraphy [1], positron emission tomography
(PET) [2], single-photon emission computed tomography (SPECT)
[3], xenon-enhanced dual-energy computer tomography (CT) [4]
and hyperpolarized noble gas (HP-) magnetic resonance imaging
(MRI) [5]. These imaging tools enable the visualization of regional
functional impairment in asthmatic lungs, and may facilitates the
early diagnosis, asthma phenotyping, the monitoring of disease
 article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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rogress, the assessment of treatment effect and the planning
f targeted therapies [6–8]. Most previous work has focused on
 component of lung function, such as ventilation, perfusion, or
entilation–perfusion mismatch. Whilst the investigation of indi-
idual contributors to functional impairment is of interest and
otentially important, the estimation of the integrated function-
lity of a regional lung unit is equally important, for example how
xygen (O2) is delivered and taken up locally. In addition, the appli-
ation of previously-described imaging techniques is hampered
y a range of limitations including the use of ionizing radiation,
he need to produce radiotracers, expense and/or practical dif-
culty in implementation [9]. A non-invasive, non-ionizing and
idely available imaging technique with the capability to assess
egional lung function may  allow more widespread use of imaging
n asthma, potentially leading to better characterization of severe
sthma patients and/or treatment stratiﬁcation, i.e. guiding topical
herapy and monitoring treatment effect.
Dynamic oxygen-enhanced (OE-) MRI  can provide spatial and
emporal information on regional delivery and uptake of O2 in
he lung by using 16O2 as a contrast agent [10–13]. The param-
gnetic O2 molecules dissolve in the tissue water and blood plasma
ithin the lung and increase the lung spin-lattice relaxation rate
R1) in proportion to dissolved O2 concentration [11] and thus
he local O2 partial pressure (PO2) [14]. By measuring the change
n lung R1 between breathing air and breathing elevated levels
f O2, the change in lung tissue PO2 (PO2) can be quantiﬁed
24, 26). The steady-state PO2 in lung water (i.e. water in blood
lasma and parenchymal tissue) in response to a step change in
nspired oxygen fraction (FiO2) reﬂects the efﬁciency of alveolar
xygenation and ventilation–perfusion matching. Additionally, the
ynamic change of PO2 yields information on regional alveolar
entilation [12,15–17].
Although OE-MRI has been used to investigate lung function
hanges in many pulmonary disorders [13,15,18–20], there is little
ata regarding its utility in asthma. Ohno et al. demonstrated an
quivalent efﬁcacy of OE-MRI to quantitative CT in the classiﬁcation
f asthma severity [21]. However, this work was based on a static
bservation of the O2-induced signal enhancement in spin-lattice
elaxation time (T1 = 1/R1) weighted images, which is potentially
ess informative than dynamic and quantitative measurement of
1 changes in reﬂecting lung function [12,19].
OE-MRI is widely available and relatively straightforward to
mplement clinically and may  provide indices relevant to asthma.
he aim of this study was  to assess the potential value of OE-MRI as
 clinical tool in asthma by exploring the feasibility, reproducibility
nd sensitivity of dynamic OE-MRI indices in the assessment of the
ocal efﬁciency of pulmonary oxygenation in patients with asthma.
. Materials and methods
.1. Study subjects
10 non-smoking asthmatic patients were recruited from Uni-
ersity Hospital of South Manchester between February 2012 and
une 2012. 4 were mild asthmatic patients who matched the crite-
ia of: (1) the percentage predicted forced expiratory volume in 1
econd (FEV1%predicted) ≥85%; (2) required treatment of low dose
nhaled corticosteroid (≤400 g/day beclomethasone dipropionate
r equivalent) or short-acting inhaled 2-adrenergic receptor ago-
ists only; (3) no requirement for oral steroid in last 12 months.
he other 6 were severe asthmatic patients who matched the crite-
ia of: (1) FEV1%predicted <85%; (2) treatment required consistent
ith step 4 or step 5 of British Thoracic Society guideline on the
anagement of asthma [22]; (3) a minimum of two  courses of
ral corticosteroid in the last 12 months. Main exclusion criteriaf Radiology 84 (2015) 318–326 319
included: age <18 or >70 years old; current smoker or ex-smoker
with pack-years >10 or smoking cessation <1 year; exacerbation
of asthma requiring an increase in maintenance oral or inhaled
glucocorticoid or acute asthma attack within the past 2 weeks; sig-
niﬁcant upper or lower respiratory tract infection within the past
6 weeks; history or signs of any past or current pulmonary disease
other than asthma; unable to perform spirometry or plethysmogra-
phy manoeuvres; daytime peripheral capillary O2 saturation (SpO2)
<90% on room air; subjects who require treatment with O2; subjects
with claustrophobia, pacemaker, clips within the brain, previous
brain or heart surgery, history of metal in the eye, body weight
>140 kg or inability to stay still in the supine position for 45 min;
history or signs of any past or current other signiﬁcant diseases,
disorders or clinically relevant abnormalities which, in the opinion
of investigator, may  put the subject at a risk when participating in
the study, inﬂuence the results of the study, or inﬂuence the sub-
ject’s ability to participate in the study, etc. All patients withheld
short-acting bronchodilators for 6 h and long-acting bronchodila-
tors for 12 h prior to each visit. The study was approved by the
National Research Ethical Committee (Ref: 11/NW/0086) and writ-
ten informed consent was  obtained from each subject. The study
was registered in UK Clinical Research Network study portfolio
database (Ref: 10270).
2.2. Clinical visit
All subjects underwent spirometry, body plethysmography and
gas transfer measurements at University Hospital of South Manch-
ester. The pulmonary function tests (PFT) were performed using
a Plethysmograph (CareFusion Ltd. Germany) according to Euro-
pean Respiratory Society recommendations [23]. The PFT indices
included the actual values and the percentage predicted values
(%predicted) of forced expiratory volume in 1 second (FEV1), forced
vital capacity (FVC), functional residual capacity (FRC), FEV1 to FVC
ratio, maximum mid-expiratory ﬂow (MMEF), total lung capacity
(TLC), residual volume (RV), RV to TLC ratio, total speciﬁc airway
resistance (sRtot), effective speciﬁc airway resistance (sReff) and
diffusing capacity of carbon monoxide (DLCO).
Asthma control test (ACT) questionnaires were completed. SpO2
was measured on room air using a pulse oximeter. Sputum and
blood samples were collected for eosinophil counting (EOSS, EOSB).
Subjects with either increased EOSs (EOSs > 3% of all sputum cells)
or increased EOSB (EOSB > 0.4 × 109/L) were deﬁned as ‘current
eosinophil positive’. The others were ‘current eosinophil negative’.
The blood and sputum eosinophil testing results within the last 3
years were also checked, according to which subjects were divided
into ‘3-year eosinophil positive/negative’ subgroups. The highest
blood eosinophil results in the last 3 years were recorded (EOSBmax).
Clinic visit took around 1–1.5 h to complete: consenting
(5–10 min), case report form and Asthma Control Test ques-
tionnaire (10 min), pulmonary function test (30–45 min), blood
sampling (5 min) and sputum sampling (5 min  if spontaneously
produce sputum/25 min for sputum induction).
2.3. Image acquisition
All subjects underwent dynamic OE-MRI scanning at Manch-
ester Wellcome Trust Clinical Research Facility within 7 days of the
clinical visit (median 4 days, interquartile range 3–5 days). A rescan
was carried out on 9 subjects approximately 4 weeks after the ﬁrst
scan (median 28 days, interquartile range 26–30 days). 1 severe
asthmatic subject reported claustrophobia and withdrew from the
second scan.
Scans were performed using a 1.5 T whole-body scanner (Philips
Achieva, The Netherlands). Subjects breathed medical air (21%
O2) and 100% O2 throughout the scans via non-rebreathing
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asks (Intersurgical Ltd., Wokingham, UK) at a ﬂow rate of
5 L/min. A single 10 mm-thick coronal oblique slice was positioned
osteriorly in the chest, angled to intersect the descending aorta.
aseline lung T1 (T1air l) measurements were made using a set of T1-
eighted centric ordered inversion-recovery single-shot turbo spin
cho sequence (IR-TSE), using a non-selective adiabatic inversion
ulse, with 5 inversion times (TI = 60/300/1100/2000/5000 ms).
here were 5 repetitions for each TI to average over the cardiac
nd respiratory cycles. This was followed by 70 dynamic acqui-
itions with a TI of 1100 ms,  during which the gas supply was
witched to 100% O2 at the 15th acquisition. After that, an addi-
ional 70 images were acquired dynamically with the gas supply
witched back to medical air at the 15th acquisition. The total
canning time was approximately 22 min. Other scanning param-
ters included: repetition time (TR) 6000 ms,  effective echo time
TE) 3.2 ms,  matrix 128 × 128 (full k-space sampling) and pixel size
.52 mm × 3.52 mm.  Images were acquired during free breathing.
o breath-holding, respiratory or cardiac triggering was  used. The
ime information about the scanning protocol is provided in Table
1.
.4. Image analysis
Image analysis was performed by using code written in Mat-
ab R2012a (MathWorks, Natick, Mass). Lungs were segmented and
egistered semi-automatically to the end inspiration position [24].
entral major blood vessels were manually segmented based on
he images with TI of 5000 ms  (reader: W.Z, 3 years’ experience
f image analysis). Images acquired with a TI = 5000 ms  provided
he highest proton density weighting and relatively high contrast
etween blood and lung tissue compared to those acquired with
ther TIs, which facilitates the manual vessel segmentation. Base-
ine T1air l maps were generated by ﬁtting the inversion recovery
ignal equation to the multiple inversion recovery images acquired
n air inhalation. Breathing elevated concentration of O2 leads to
 shortening of T1(= 1/R1) and a corresponding increase in sig-
al intensity in the dynamic T1-weighted images. The signal time
ourse curves throughout the gas switchover were converted to
ynamic T1 curves using the baseline T1air l maps and the sig-
al equation [25]. The dynamic T1 curves were then converted to
ynamic changes in the partial pressure of O2 dissolved in the tissue
ater and plasma of the lung by
PO2(t) =
1/T1(t) − 1/T1air
ro2
(1)
sing a value for the O2 longitudinal relaxivity in water (rO2) of
.49 × 10 −4/s mmHg  [14]. T1 maps on O2 plateau (T1oxy l) were
alculated as the average of the last 10 points in the dynamic T1
urves. For each pixel within the lung, an independent samples t-
est (one-tailed) was performed to compare the ﬁrst 14 data points
nd the last 15 data points on the O2 wash-in PO2 (t) curve. Pixels
ith signiﬁcantly increased PO2 were considered as demonstrating
nhancement due to oxygen breathing. The fraction of the enhanc-
ng pixels over the lung was denoted as the enhancing fraction (EF).
he lung PO2 (t) curves of the enhancing pixels were then ﬁt-
ed using exponential functions for the O2 wash-in portion of the
ynamic curve and for the O2 wash-out portion of the dynamic
urve:
ash-in : PO2(t) = PO2 max(1 − exp(−t/up)) (2)
ash-out : PO2(t) = PO2 max exp(−t/down) (3)
here up l and down l represent the O2 wash-in and wash-out
ime constants in units of min−1 and PO2max l is the maximum
ung PO2 in mmHg  after switching air to 100% O2. PO2max l
as summarized using the median and the interquartile range (1)f Radiology 84 (2015) 318–326
across the entire lungs in the ﬁeld of view (with the non-enhancing
pixels assigned as PO2max = 0), and (2) over the enhancing lung
regions only. up l and down l were summarized over the enhanc-
ing lung regions only. Median T1air l and median T1oxy l across the
entire lungs in the ﬁeld of view were measured. Similar imaging
parameters of the arterial blood in aorta (T1air a, PO2max a, up a
and down a) were calculated in the same way using a region of
interest deﬁned in the descending aorta [26].
2.5. Statistical analysis
Between-group comparisons were performed by using 2
test (nominal data: gender and eosinophilic status) and the
independent-samples t-test (discrete data: ACT score; continuous
data: all the other parameters). The normality and the homo-
geneity of variances of the discrete data and continuous date
were tested ahead of the independent-sample t-test by using
Kolmogorov–Smirnov test and Levene’s test, respectively. Pear-
son’s correlation analysis was  used to explore the association
between clinical measurements and dynamic OE-MRI readouts.
All inter-group analysis was performed using the ﬁrst scan data.
Bland–Altman analysis was used to estimate the scan-rescan agree-
ments and intra-observer agreements of the dynamic OE-MRI
readouts A P value of less than 0.05 (two-tailed) was taken to indi-
cate statistical signiﬁcance. No multiplicity correction was  made
owing to the exploratory nature of the work and the small sample
size involved. Analysis was performed using SPSS 20.0 (SPSS Inc.,
Chicago, USA).
3. Results
3.1. Demographic and clinical information
Demographic information and clinical measurements are sum-
marized in Table 1. Compared to the mild asthmatic group,
the severe asthmatic group was  on average older (P = 0.030)
with a larger body mass index (BMI, P = 0.020), worse air-
way obstruction (FEV1%predicted, FVC%predicted, FEV1/FVC and
MMEF%predicted; P = 0.001, 0.011, 0.005 and 0.001, respec-
tively), air trapping (RV/TLC, P = 0.003) and airway resistance
(sRtot%predicted, sReff%predcited; P = 0.002 and 0.003, respec-
tively). 2 out of 4 mild asthmatics and 4 out of 6 severe
asthmatics were genuine eosinophilic asthma patients (3-year
eosinophil positive). There was  no statistically signiﬁcant dif-
ference in the ACT score (P = 0.125), SpO2 (P = 0.060), EOBB
(P = 0.766), EOBS (P = 0.384), EOBSmax (P = 0.060) and diffusion
capacity (DLco%predicted, P = 0.509) between groups.
3.2. Dynamic OE-MRI of the lung
Example imaging parameter maps (scan and rescan) from a mild
asthmatic patient (19 years old, female, FEV1%predicted = 99%) are
shown in Fig. 1. Example maps from a severe asthmatic patient (19
years old, female, FEV1%predicted = 69%) are presented in Fig. 2.
The corresponding parameter histograms for these two  subjects
are shown in Fig. E1. The mild asthmatic patient shows relatively
homogeneous maps of PO2max l, up l and down l with approxi-
mately all the lung regions enhancing (EF is 100% and 97% in the
two scans, respectively). The repeat parameter maps were visibly
similar to each other. By contrast, the parameter maps from the
severe asthmatic patient are relatively heterogeneous, with some
areas of low PO2max l values and some areas of high up l and
down l values. Moreover, a large portion of the lungs (lower part,
both sides) did not enhance after the O2 administration (EF is 82%
and 67% in the two scans, respectively) in both scans. There is visi-
bly less agreement between the maps obtained from the two visits
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iig. 1. Dynamic OE-MRI parameter maps from a mild asthmatic participant (femal
f  PO2max up l and down l from the ﬁrst scan, respectively. d–f are the maps of PO
or  the ﬁrst scan and 97% in the second scan.
or the severe asthmatic (Fig. 2) patient than for the mild asthmatic
atient (Fig. 1). The histograms of PO2max l, up l and down l from
he mild asthmatic patient (Fig. E1a–c) are narrower with a higher
nd sharper peak than the histograms from the severe asthmatic
atient (Fig. E1d–f).
The group averaged histograms of the dynamic OE-MRI param-
ter maps are provided in Fig. E2. The histogram of PO2max l has
arkedly lower values in the severe asthmatic group than in the
ild asthmatic group (Fig. E2a). The histograms of up l (Fig. E2b)
nd down l (Fig. E2c) in the severe asthmatic group were wider, as
emonstrated by the larger interquartile range, with a lower peak
han those in the mild asthmatic group.
ig. 2. Dynamic OE-MRI parameter maps from a severe asthmatic participant (female, 1
aps  of PO2max up l and down l from the ﬁrst scan, respectively. d–f are the maps of 
s  82% in the ﬁrst scan and 67% in the second scan.years old, FEV1%predicted = 99%) from scan (V1) and rescan (V2). a–c are the maps
up l and down l from the second scan, respectively. The enhancing fraction is 100%
The time course curves of the entire-lung median PO2 were
averaged across the groups and then plotted in Fig. 3. The curve
from the severe asthmatic group showed a lower PO2 plateau
than that of the mild asthmatic group, consistent with the ﬁndings
shown in Fig. E2a.
The imaging readouts of each individual are listed in
Table E2 and the comparison of these parameters between
the two asthmatic groups is shown in Table 2. There was
no signiﬁcant difference in median T1air l and median T1oxy l
between mild and severe asthmatic groups. There were signif-
icantly lower EF (70 ± 16%, P = 0.014) and entire-lung median
PO2max l (156 ± 52 mmHg, P = 0.004) as well as signiﬁcantly wider
9 years old, FEV1%predicted = 64%) from the scan (V1) and rescan (V2). a–c are the
PO2max up l and down l from the second scan, respectively. The enhancing fraction
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Table  1
Demographic data and clinical measurements.
Parametera Mild asthmab
(n = 4)
Severe asthmab
(n = 6)
P valuec
Age, years 23 ± 5 41 ± 12 0.033
Sex,  male/female 2/2 3/3 1.000
BMI, kg/m2 25 ± 2 34 ± 6 0.021
ACT  score 20 ± 3 14 ± 6 0.125
SpO2, % 98 97 0.060
EOSS, % 0.5 ± 0.7 11.1 ± 19.1 0.384
EOSB, 109/l 0.4 ± 0.2 0.5 ± 0.8 0.766
EOSBmax, 109/L 0.4 ± 0.2 1.2 ± 0.8 0.060
Current EOS status, +/− 2/2 2/4 0.598
3-year EOS status, +/− 2/2 4/2 0.598
FEV1, % predicted 96 ± 3 60 ± 14 0.001
FVC, % predicted 110 ± 1 94 ± 9 0.011
FEV1/FVC, % 75 ± 3 54 ± 12 0.005
MMEF, % predicted 62 ± 3 18 ± 11 0.001
FRC, % predicted 120 ± 16 136 ± 35 0.423
TLC,  % predicted 111 ± 5 118 ± 17 0.453
RV,  % predicted 142 ± 39 181 ± 54 0.263
RV/TLC, % predicted 32 ± 5 49 ± 6 0.003
sRtot, kPa s 1.3 ± 0.4 3.6 ± 1.1 0.007
sRtot, % predicted 116 ± 25 321 ± 74 0.002
sReff, kPa s 1.1 ± 0.4 3.4 ± 1.1 0.008
sReff, % predicted 102 ± 25 303 ± 76 0.003
DLCO, % predicted 82 ± 13 78 ± 8 0.509
a BMI: body mass index; ACT: Asthma Control Test questionnaire; EOSS: sputum
eosinophil counting; SpO2: peripheral capillary oxygen saturation when subjects
breath room air; EOSB: blood eosinophil counting; EOSBmax: the highest blood
eosinophil counting in the last 3 years; Current EOS status: current eosinophil sta-
tus;  3-year EOS status: long term eosinophil status according to the sputum and
blood eosinophil testing results in the last 3 years; FEV1: forced expiratory volume
in  1 s; %predicted: percentage of predicted normal value; FVC: forced vital capacity;
MMEF: maximum mid-expiratory ﬂow; FRC: functional residual capacity; TLC: total
lung capacity; RV: residual volume; RV/TLC: ratio of RV to TLC; sRtot: total speciﬁc
airway resistance; sReff: effective speciﬁc airway resistance; DLCO: diffusing capacity
for  carbon monoxide.
b
p
i
a
2
Fig. 3. The group averaged time course curves of median PO2 (mmHg) over the
entire lung in mild asthma group (red solid line) and severe asthma group (blue solid
line). The red stars (mild asthma) and blue dots (severe asthma) are the individual
T
C
p
l
wData are means ± standard deviations.
c P value is from the independent sample t-test or the 2 test. P values < 0.05 are
resented in bold.nterquartile range of up l (0.84 ± 0.26 min, P = 0.001) in the severe
sthmatic group than in the mild asthmatic group (95 ± 3%;
81 ± 40 mmHg; 0.20 ± 0.07 min), while no signiﬁcant difference
able 2
omparison of the dynamic OE-MR imaging readouts between the two  asthmatic groups
Parametera Mild asthmab
(n = 4)
Lung
EF, % 95 ± 3 
Calculation performed over the entire lung in the ﬁeld of view
Median T1air l , ms  1204 ± 43 
Median T1oxy l , ms 1009 ± 47 
Median PO2max l, mmHg 281 ± 40 
Interquartile range of PO2max l , mmHg  137 ± 53 
Calculation performed over the enhancing lung regions in the ﬁeld of view
Median PO2max l , mmHg 286 ± 42 
Interquartile range of PO2max l , mmHg  127 ± 49 
Median up l , min  0.56 ± 0.10 
Interquartile range of up l , min  0.20 ± 0.07 
Median down l , min  0.68 ± 0.52 
Interquartile range of down l , min  0.97 ± 1.49 
Aorta
T1air a, ms  1338 ± 82 
PO2max a, mmHg  306 ± 99 
up a, min 0.68 ± 0.60 
down a, min  0.53 ± 0.18 
a EF: enhancing fraction; T1air l: longitudinal relaxation time of the lung parenchyma w
arenchyma when subject breathing 100% oxygen; PO2max l: the maximal change in th
ung;  up l: oxygen wash-in time constant of the lung; down l: oxygen wash-out time con
hen  subject breathing medical air; up a: oxygen wash-in time constant of the arterial b
b Data are means ± standard deviations.
c P values are from Independent-samples t-test. P values < 0.05 are presented in bold.values. (For interpretation of the references to color in this ﬁgure legend, the reader
is  referred to the web  version of the article.)
was observed in the median up l (P = 0.099), median down l
(P = 0.676), entire-lung interquartile range of PO2max l (P = 0.508)
and interquartile range of down l (P = 0.651). The median PO2max l
remained signiﬁcantly different between the groups when the
calculation was performed over the enhancing lung regions only
(severe asthmatic group vs mild asthmatic group = 183 ± 42 mmHg
vs 286 ± 42 mmHg, P = 0.005).
No signiﬁcant between-group difference was found in the imag-
ing readouts when asthmatic subjects were divided according to
the current or the 3-year eosinophil status (not shown).
Table 3 lists the Pearson’s correlation coefﬁcients between
the imaging readouts of the lung and the clinical measure-
ments in all asthmatic subjects. Example scatter plots are
provided in Fig. E3 to show the strongest correlation of imag-
ing readouts with the PFT indices. EF and median PO2max l
showed strong and positive correlations with FEV1%predicted,
FVC%predicted, FEV1/FVC and MMEF%predicted (r = 0.750–0.879,
.
Severe asthmab
(n = 6)
P valuec
70 ± 16 0.014
1158 ± 70 0.273
1113 ± 59 0.894
156 ± 52 0.004
173 ± 91 0.508
183 ± 42 0.005
127 ± 76 0.998
0.76 ± 0.20 0.099
0.84 ± 0.26 0.001
0.86 ± 0.71 0.676
1.41 ± 1.47 0.651
1333 ± 122 0.945
199 ± 90 0.112
1.58 ± 0.76 0.035
1.29 ± 0.81 0.071
hen subject breathing medical air; T1oxy l: longitudinal relaxation time of the lung
e partial pressure of dissolved oxygen in the blood plasma and tissue water of the
stant of the lung; T1air a: longitudinal relaxation time of the arterial blood in aorta
lood in aorta; down a: oxygen wash-out time constant of the arterial blood in aorta.
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Table  3
Pearson’s correlation coefﬁcients between the dynamic OE-MR imaging readouts of the lung and the clinical measurements in all asthmatic subjects.
Parametera EF (%)a,b Median PO2max l
(mmHg), entire lunga,b
Median PO2max l
(mmHg), EFa,b
Interquartile range of up l
(min), EFa,b
Median down l (min),
EFa,b
Interquartile range of
down l (min), EFa,b
Age, years −0.835 (0.003) −0.817 (0.004) −0.742 (0.014) 0.678 (0.031) 0.465 (0.176) 0.444 (0.198)
FEV1, % predicted 0.858 (0.002) 0.750 (0.012) 0.676 (0.032) −0.847 (0.002) −0.297 (0.405) −0.167 (0.644)
FVC,  % predicted 0.787 (0.007) 0.539 (0.108) 0.451 (0.191) −0.927 (<0.001) −0.034 (0.925) 0.024 (0.947)
FEV1/FVC, % 0.836 (0.003) 0.773 (0.009) 0.700 (0.024) −0.734 (0.016) −0.432 (0.212) −0.280 (0.433)
MMEF, % predicted 0.879 (0.001) 0.831 (0.003) 0.771 (0.009) −0.889 (0.001) −0.329 (0.353) −0.257 (0.473)
sRtot, kPa s −0.873 (0.002) −0.868 (0.002) −0.835 (0.005) 0.684 (0.042) 0.467 (0.205) 0.327 (0.391)
sRtot, % predicted −0.863 (0.003) −0.872 (0.002) −0.850 (0.004) 0.700 (0.036) 0.403 (0.282) 0.264 (0.492)
SReff, kPa s −0.860 (0.003) −0.860 (0.003) −0.829 (0.006) 0.677 (0.045) 0.458 (0.215) 0.314 (0.411)
SReff, % predicted −0.851 (0.004) −0.864 (0.003) −0.844 (0.004) 0.694 (0.038) 0.399 (0.287) 0.257 (0.505)
FRC,  % predicted −0.634 (0.066) −0.624 (0.072) −0.577 (0.104) 0.196 (0.613) 0.905 (0.001) 0.770 (0.015)
TLC,  % predicted −0.562 (0.120) −0.620 (0.075) −0.596 (0.090) 0.067 (0.864) 0.886 (0.001) 0.724 (0.027)
RV,  % predicted −0.594 (0.090) −0.628 (0.070) −0.612 (0.080) 0.361 (0.340) 0.794 (0.011) 0.722 (0.028)
RV/TLC, % −0.904 (0.001) −0.926 (<0.001) −0.911 (0.001) 0.748 (0.020) 0.613 (0.080) 0.552 (0.123)
a EF: enhancing fraction; Median PO2max l , entire lung: the median value of the maximal change in the partial pressure of dissolved oxygen in the blood plasma and tissue
water  over the entire lungs in the ﬁeld of view; Median PO2max l , EF: the median value of the PO2max l over the enhancing lung regions in the ﬁeld of view; Interquartile
range  of up l, EF: the interquartile range of oxygen wash-in time constant over the enhancing lung regions in the ﬁeld of view; Median down l, EF: oxygen wash-out time
constant over the enhancing lung regions in the ﬁeld of view; Interquartile range of down l , EF: the interquartile range of down l over the enhancing lung regions in the ﬁeld
of  view; FEV1: forced expiratory volume in 1 s; % predicted: percentage of predicted normal value; FVC: forced vital capacity; MMEF: maximum mid-expiratory ﬂow; sRtot:
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capacity according to DLCO%predicted (78%–82%). The up and downotal  speciﬁc airway resistance; sReff: effective speciﬁc airway resistance; FRC: fun
V  to TLC.
b Data are presented as correlation coefﬁcient (P value). P values < 0.05 are presen
 = 0.001–0.012) while strong and negative correlations with age,
Rtot%predicted, sReff%predicted, RV%predicted and RV/TLC
r = −0.926 to −0.817, P = 0.001–0.004). The interquartile
ange of up l was signiﬁcantly and negatively correlated with
EV1%predicted, FVC%predicted, FEV1/FVC and MMEF%predicted
r = −0.927 to −0.734, P = 0.001–0.016) while signiﬁcantly and pos-
tively correlated with sRtot%predicted, sReff%predicted and
V/TLC (r = 0.678–0.748, P = 0.020–0.045). The median and
nterquartile range of down l were positively correlated with
RC%predicted, TLC%predicted and RV%predicted (r = 0.722–0.905,
 = 0.001–0.028), but not with age or the other PFT indices. There
as no signiﬁcant linear correlation of the interquartile range of
PO2max l and median up l with the PFT parameters. There was  no
tatistically signiﬁcant linear correlation of BMI, ACT score, EOSS,
OSB, EOSBmax or DLCO%predicted with any imaging readouts.
here was no statistically signiﬁcant linear correlation of ACT
core, EOSS, EOSB or EOSBmax with PFT parameters.
.3. Dynamic OE-MRI in the aorta
A statistically signiﬁcant difference was found in up a between
he two groups (P = 0.030), but not in T1air a, PO2max a and
down a (Table 2). PO2max a was positively correlated with median
PO2max l (entire-lung median and enhanced-region median, both
 = 0.745, both P = 0.013, Spearman’s rank correlation).
.4. One-month reproducibility
The imaging parameter maps from the scan and rescan (1 month
part) were similar in mild asthmatic subjects while relatively more
ariable in severe asthmatic subjects, as shown in the examples in
igs. 1 and 2. The degree of agreement between the two measure-
ents of the imaging readouts is illustrated by the Bland–Altman
lots in Fig. E4. The mean bias, 95% conﬁdence interval of the
ias and the limits of agreement between the two  measurements
or each dynamic OE-MRI parameter are listed in Table E3. The
land–Altman plots demonstrate that the mean bias between the
can and rescan imaging measurements did not signiﬁcantly devi-
te from zero (P > 0.05, one-sample t-test). The mild asthmatic
roup presents less variation between repeat measurements with
arrower limits of agreements and bias closer to zero than the
evere asthmatic group.l residual capacity; TLC: total lung capacity; RV: residual volume; RV/TLC: ratio of
 bold.
3.5. Intra-observer agreement
The mean bias for intra-observer agreements (95% limits of
agreement) in dynamic OE-MRI parameters was listed in Table E4.
The mean bias between the two  measures of a single observer did
not signiﬁcantly deviate from zero (P > 0.05, one-sample t-test).
4. Discussion
This prospective pilot study provides initial evidence of the fea-
sibility and the one-month reproducibility of dynamic OE-MRI in
the quantitative estimation of O2 delivery, uptake and washout in
asthmatic lungs.
We have demonstrated that the dynamic OE-MRI technique is
able to visualize regional functional abnormalities in patients with
asthma. The patchier appearance of the imaging parameter maps
and the broader parameter histograms in severe asthmatic lungs
than in mild asthmatic lungs clearly reﬂects the increased het-
erogeneity of lung functional impairment in more severe asthma.
These inhomogeneous patterns are consistent with those seen in
other asthma imaging studies [2,21]. The non-enhancing regions
observed in the lungs may  indicate the presence of severe airway
occlusion, probably due to mucus plugging, airway remodelling
or airway spasm, resulting in low alveolar ventilation. PO2max l
maps provide valuable spatial information about pulmonary oxy-
genation, i.e. the maximum increase in lung water PO2 observed
after a step change in inspired oxygen fraction. The low value
regions in PO2max l, which are more prominent in severe asth-
matic lungs, imply reduced ability to deliver O2, as we  would expect
a low ventilation–perfusion ratio, which can occur even in asymp-
tomatic asthma [27], to lead to low local PO2. Averaged across the
whole lung the ventilation–perfusion impairment in severe asth-
matics was  not sufﬁciently large to signiﬁcantly reduce PO2max a,
although the wash-in time, up a, was signiﬁcantly longer in the
severe asthmatic group, probably indicating reduced total venti-
lation across the lung, consistent with the worse lung function
demonstrated in the PFTs. Although diffusion impairment may  also
lead to decreased pulmonary oxygenation efﬁciency, this is not the
case in this study as approximately all subjects had normal diffusionmaps represent the time constants for regional pulmonary oxygen
delivery and the prolonged wash-in and wash-out time constants
in severe asthmatics reﬂect regional airﬂow limitation.
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We  have also shown that OE-MRI readouts are sensitive to
sthma severity. EF and median PO2max l are signiﬁcantly lower
n severe asthmatic patients than in mild asthmatic patients.
hese differences are expected as studies have shown that poor
entilation, ventilation–perfusion inequality and shunt are exac-
rbated with increased asthma severity [28], all of which could
ontribute to inefﬁcient pulmonary oxygenation. Furthermore, not
nly the entire-lung median but also the enhancing-region median
f PO2max l differed signiﬁcantly between groups, which indicates
hat PO2max l was lower even in the absence of gross obstruc-
ion or constriction in the severe asthmatics’ lungs. The signiﬁcant
orrelation of median PO2max l with PO2max a, an index of the
verall oxygenation efﬁciency within the lungs, accords with an
arly OE-MRI experiment on a pig where an excellent linear corre-
ation was demonstrated between the lung tissue R1 and the PO2
f the arterial blood sampled from right femoral artery (r2 = 0.997)
16]. This correlation suggests that single slice PO2max l measure-
ent could to some extent reﬂect global lung functional status in
ddition to providing unique regional information.
The interquartile range of up l is also sensitive to asthma sever-
ty. The signiﬁcantly wider interquartile range of up l and the
orrespondingly broader up l histogram in the severe asthmatic
ungs implies a more heterogeneously distributed airﬂow limita-
ion than in mild asthmatic lungs. The median up l and median
down l in our two asthmatic groups are comparable to previously
ublished values in patients with chronic obstructive pulmonary
isease [15] while longer than that in healthy subjects [15,16]. The
etween-group difference in median up l and median down l did
ot reach statistical signiﬁcance, most likely owing to the small
ample size and the relatively large variation. Baseline T1 of the
ung was comparable in the two asthmatic groups and was simi-
ar to normal lung T1 [24]. However under hyperoxia, lung T1 was
hortened due to oxygen inhalation by about 7.5% in mild asthmatic
atients, which was a larger change than the 3.6% T1 shortening in
evere asthmatic patients in this study while comparable to the lit-
rature values in healthy lungs (6%–17% T1 shortening; note that T1
hortening contains essentially the same information as the PO2
ata we have presented due to the nature of the PO2 calculation)
16,24,29].
The third ﬁnding is the substantial correlations between the
maging readouts and the PFT measurements in asthma. EF, median
PO2max l and the interquartile range of up l were strongly corre-
ated with PFT indices of airway function. The entire-lung median
PO2max l showed slightly better correlations with PFT parameters
han the enhancing-region median PO2max l. Similar correla-
ions of OE-MRI readouts with FEV1%predicted, FVC%predicted,
EV1/FVC ratio and MMEF%predicted have been demonstrated in
sthmatics and patients with other lung diseases [13,15,19–21],
hile the correlations with the airway resistance indices of sRtot
nd sReff are to our knowledge the ﬁrst reported. In a previous
sthma OE-MRI study, Ohno et al. reported signiﬁcant but much
eaker correlations between the mean signal enhancement ratio
nd FEV1 (r = 0.55, P < 0.05) and the average forced expiratory ﬂow
etween 25% point and 75% point of FVC (FEF25%–75%, r = 0.55,
 < 0.05) [21]. The stronger correlations presented in our study
robably beneﬁt from our use of quantitative T1 measurements in
 dynamic manner, which is likely to be more precise in evaluating
ung function than the simple observation of static signal intensity
hange, as changes in relaxation rate relate linearly to changes in
xygen partial pressure [12,19]. Unlike other imaging parameters,
edian and interquartile range of down l showed strong correla-
ions with TLC%predicted and RV%predicted but not with other PFT
ndices. This observation might imply the underlying differences
etween the O2 wash-in and wash-out processes, with O2 wash-
n more prominently associated with the forced expiratory ﬂow
ate [12,15] while O2 wash-out is more related to lung volumef Radiology 84 (2015) 318–326
measurements. Signiﬁcant correlations between DLCO%predicted
and the OE-MRI imaging readouts have been observed in patients
with COPD and interstitial lung disease [15,20] but not in healthy
subjects [12] or in the asthmatic patients in the current study.
DLco%predicted is more affected in emphysematous COPD and
interstitial lung disease than in asthma and thus is an essential
determinant of OE-MRI readouts in the former two diseases. In
contrast to the good sensitivity to lung function, dynamic OE-MRI
readouts failed to differentiate the airway inﬂammatory pheno-
types (eosinophilic/non-eosinophilic) and were not associated with
the level of airway inﬂammation in this study. However, consider-
ing most patients were undergoing anti-inﬂammatory/anti-allergic
treatment that alter the eosinophil levels, this observation needs to
be further explored by future studies with larger sample size and
controlled therapies.
Dynamic OE-MRI showed good one-month reproducibility in
mild asthmatic patients, as evidenced by the similar parameter
maps between scans and the narrow limits of agreement in the
Bland–Altman plots. The visit-to-visit variability in the severe asth-
matic group is likely to be derived from the true disease-related
variation of airway changes over the one month interval. It seems
less likely that potential technical issues, for example the difference
in image location between repeat scans, are the cause of differ-
ences, as the differences were much smaller in the mild asthmatic
group. The stability of the geographic location of ventilation defects
in severe asthmatic patients at the lobe level (as the example in
Fig. 2), also seen with serial hyperpolarized helium-3 MRI  ventila-
tion imaging, implies the existence of ﬁxed airway obstruction due
to airway remodelling in severe asthma [30]. To our knowledge, this
is the ﬁrst report of the reproducibility of the OE-MRI technique in
asthma. In addition, dynamic OE-MRI analysis showed reasonable
intra-observer agreements in both mild asthmatic group and severe
asthmatic group.
There are several technical and statistical limitations to this
study. Firstly, the single slice MR  imaging of our method restricts
the application of dynamic OE-MRI for the assessment of whole
lung function or guiding the topical therapy. Considering the
structural and functional impairments in asthmatic lungs are het-
erogeneous, a volumetric acquisition with whole lung coverage
must be achieved before dynamic OE-MRI can be introduced for
clinical use. Recently, a standard single-shot three-dimensional
magnetization prepared rapid gradient echo sequence has been
successfully employed for whole lung volumetric dynamic OE-MRI
in healthy subjects [31]. It is expected to extend this sequence
to patients with asthma after further validation. Secondly, we
assumed that the O2 relaxivity in water is approximately the
same as that in the lung tissue. However, they may be different
and thus cause errors in PO2max l estimation. Nevertheless, as
the calculated PO2max l varies linearly with the relaxivity con-
stant, it does not alter the conclusion of this study. Experiments
are needed to measure the O2 relaxivity in lung tissue but this
is a non-trivial measurement to perform. Thirdly, there were no
CT measures of airway wall thickening or air-trapping (low X-
ray attenuation area under – 850 Hounsﬁeld units) available in
this study to explore the structural and functional relationship
changes in asthmatic lungs by correlating them with the dynamic
OE-MRI metrics. It is an interesting topic deserving future investi-
gation. Additional studies are also required in order to standardize
dynamic OE-MRI and test the sensitivity of this technique to the
lung functional changes in asthma caused by disease progress or
treatment. Statistically, the small patient cohort without normal
controls may  affect the impact of the statistical analysis. No mul-
tiplicity correction was made owing to the exploratory nature of
the work and the small sample size involved. In addition, age was
found correlated with imaging readouts and different between mild
and severe asthmatic groups and hence a potentially confounding
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actor inﬂuencing the group comparisons of the imaging parame-
ers.
In conclusion, our work demonstrated the promise of dynamic
E-MRI in visualizing and quantifying regional lung functional
bnormalities in asthma. Quantitative dynamic OE-MRI readouts,
ith good one-month repeatability, may  have a role in the esti-
ation of disease severity in asthma, providing differentiation
etween mild and severe asthmatic groups and demonstrating
orrelations with lung function tests, and hence contributing to
he monitoring of disease progress and the assessment treatment
ffects. The heterogeneous distribution of parameter maps from
ynamic OE-MRI reﬂects the localized nature of lung functional
mpairment in asthma and suggests a potential application of this
echnique for pre-procedure planning and post-procedure assess-
ent for asthma targeted therapies (e.g. bronchial thermoplasty),
roviding that the volumetric acquisition can be achieved. The spa-
ial and temporal information of O2 delivery, uptake and washout
n the lungs captured by dynamic OE-MRI using a cheap and non-
onising source of contrast makes it an attractive option in the
ssessment of asthma. The simple setup requirement makes this
echnique practicable for clinical usage. Given that this is a pilot
tudy, further work is certainly required to validate and extend
ndings in large age-matched cohorts and to assess sensitivity
f dynamic OE-MRI to lung function changes due to intervention
efore this technique could be used in routine clinical practice.
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